Notably, interleukins (IL1A, IL1B, and IL6) are one of the strongest evidence of inflammatory agents that increase the risk of AD and significant polymorphisms are implicated in AD as demonstrated in several case/control studies [44]. Here, IL1A is linked to Alzheimer disease.